Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
10.1016/j.meatsci.2010.05.019 27
Inflammatory bowel disease and pancreatitis: a review
Study: Triple-Hormone-Receptor Agonist Retatrutide for Obesity Journal: New England Journal of Medicine (NEJM) ClinicalTrials ID: NCT04881760 View Full Study Retatrutide is a glucagon, GLP-1, and GIP (triple hormone) receptor agonist being investigated to treat obesity
Procurement and PI sign-offs can pull historical lot data directly from the page, which makes audit trails easier to build before a purchase order goes out
US$ 22.63
US$ 29.23
US$ 22.41
US$ 29.27
US$ 27.31
US$ 22.78
US$ 28.44
US$ 20.47
US$ 22.22
US$ 23.10
